Description

Levodopa Related Compound A (50 Mg) (3-(3,4,6-Trihydroxyphenyl)-Alanine) is a high-purity chemical reference standard and synthetic intermediate. This compound is critical for ensuring the quality, safety, and efficacy of pharmaceutical products, particularly in the analysis and development of treatments for Parkinson's disease. It is primarily used by research institutions, analytical laboratories, and pharmaceutical manufacturers engaged in method development, impurity profiling, and quality control of active pharmaceutical ingredients (APIs).

Application

• Pharmaceutical Reference Standard: Used as a certified impurity standard for the quantitative and qualitative analysis of Levodopa (L-DOPA) and related pharmaceutical formulations.
• Impurity Profiling & Method Development: Essential for developing and validating analytical methods (HPLC, LC-MS) to identify and quantify related substances in drug substances and products.
• Pharmaceutical Research & Development: Serves as a key intermediate or metabolite analog in the synthesis and metabolic pathway studies of catecholamine-based therapeutics.
• Quality Control (QC) & Quality Assurance (QA): Employed in in-house QC laboratories to monitor batch-to-batch consistency and ensure compliance with pharmacopeial specifications (USP, EP).
• Regulatory Compliance & Documentation: Supports regulatory filings by providing definitive characterization and control of potential impurities as required by ICH guidelines.
• Academic & Biochemical Research: Utilized in studies investigating tyrosine metabolism, catecholamine biosynthesis, and neurological disorders.

Basic Information

Product Name	Levodopa Related Compound A (50 Mg) (3-(3,4,6-Trihydroxyphenyl)-Alanine)
CAS No.	27244-64-0
Molecular Formula	C9H11NO5
Molecular Weight	213.19 g/mol
Synonyms	3-(3,4,6-Trihydroxyphenyl)alanine; 2-Amino-3-(3,4,6-trihydroxyphenyl)propanoic acid; L-DOPA Related Compound A; 6-Hydroxy-DL-DOPA; 2,4,5-Trihydroxy-L-phenylalanine; 3,4,6-Trihydroxy-L-phenylalanine; DL-6-Hydroxydopa; 6-OH-DOPA
EINECS	Contact for details

Quality Control

Our Levodopa Related Compound A is manufactured and tested under strict quality systems to ensure it meets the exacting standards required for pharmaceutical analysis. Each batch is accompanied by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We support compliance with major pharmacopeias (USP/EP) and ICH guidelines, ensuring reliability for your critical quality control and regulatory submission needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive); ensure the container is sealed after each use to prevent degradation from atmospheric moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any individual impurity ≤ 1.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.